XML 53 R111.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Reporting - Reconciliation of Segment Profits to Income Before Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]      
Interest income $ 274 $ 343 $ 385
Interest expense (893) (772) (754)
Depreciation and amortization (3,652) (4,519) (4,676)
Research and development (9,872) (9,752) (10,339)
Restructuring costs (638) (632) (776)
Loss on extinguishment of debt     (191)
Income Before Taxes 11,464 8,701 6,521
Total segment profits      
Segment Reporting Information [Line Items]      
Depreciation and amortization (256) (335) (212)
Income Before Taxes 29,926 26,633 24,845
Total segment profits | Pharmaceutical segment      
Segment Reporting Information [Line Items]      
Depreciation and amortization (137) (243) (125)
Income Before Taxes 28,324 24,871 23,018
Total segment profits | Animal Health      
Segment Reporting Information [Line Items]      
Depreciation and amortization (109) (82) (75)
Income Before Taxes 1,609 1,659 1,552
Total segment profits | Other segments      
Segment Reporting Information [Line Items]      
Depreciation and amortization (10) (10) (12)
Income Before Taxes (7) 103 275
Other profits      
Segment Reporting Information [Line Items]      
Income Before Taxes 363 6 26
Unallocated      
Segment Reporting Information [Line Items]      
Interest income 274 343 385
Interest expense (893) (772) (754)
Depreciation and amortization (1,573) (1,334) (1,378)
Research and development (9,499) (9,432) (10,004)
Amortization of purchase accounting adjustments (1,419) (2,664) (3,056)
Restructuring costs (638) (632) (776)
Charge related to the termination of a collaboration with Samsung 0 (423) 0
Loss on extinguishment of debt 0 0 (191)
Other unallocated, net $ (5,077) $ (3,024) $ (2,576)